| 5LQB: reference: Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2., Arenas-Ramirez N, Zou C, Popp S, Zingg D, Brannetti B, Wirth E, Calzascia T, Kovarik J, Sommer L, Zenke G, Woytschak J, Regnier CH, Katopodis A, Boyman O, Sci Transl Med. 2016 Nov 30;8(367):367ra166. PMID: 27903862 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).